Author:
Patterson Carolyn E.,Lum Hazel,Johan Groeneveld A.B.
Reference390 articles.
1. OPTIMIST Trial Study Group. Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis;Abraham;JAMA,2003
2. Complement and complement regulatory proteins as potential molecular targets for vascular diseases;Acosta;Curr. Pharm. Design,2004
3. Microvascular permeability and number of tight junctions are modulated by CAMP;Adamson;Amer. J. Physiol.,1998
4. Compounds that increase CAMP prevent ischemia-reperfusion pulmonary capillary injury;Adkins;J. Appl. Physiol,1992
5. Platelet-derived lysophosphatidic acid decreases endothelial permeability in vitro;Alexander;Amer. J. Physiol.,1998
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献